Brief: Acumen Pharmaceuticals, Inc. Q1 Income From Operations USD -30.37 Million
May 13 (Reuters) - Acumen Pharmaceuticals, Inc. Q1 basic EPS USD -0.48. Q1 net income USD -28.796 million Q1 operating expenses USD 30.37 million
May 13 (Reuters) - Acumen Pharmaceuticals, Inc. Q1 basic EPS USD -0.48. Q1 net income USD -28.796 million Q1 operating expenses USD 30.37 million